Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Giannessi · SciRah

Researcher profile · Semantic Scholar

P. Giannessi

Share profile

P. Giannessi — researcher profile on SciRah

h-index: 10
Works: 38
Citations: 595

Most-cited papers

Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial.
D. Cardinale, F. Ciceri, Roberto Latini, M. Franzosi +131 more
2018European Journal of Cancer217 citations
Semantic Scholar
Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma
P. Conte, V. Guarneri, P. Bruzzi, T. Prochilo +11 more
2004Cancer78 citations Open access
Semantic Scholar
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.
E. Baldini, G. Gardin, P. Giannessi, G. Evangelista +8 more
2003Annals of Oncology70 citations Open access
Semantic Scholar
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers.
Paola Collecchi, E. Baldini, P. Giannessi, A. Naccarato +6 more
1998European Journal of Cancer49 citations
Semantic Scholar
Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety
E. Baldini, T. Prochilo, B. Salvadori, A. Bolognesi +9 more
2004British Journal of Cancer35 citations Open access
Semantic Scholar
Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial.
P. Conte, P. Giannessi, J. Latreille, L. Mauriac +3 more
1994Annals of Oncology26 citations
Semantic Scholar
Tamoxifen and interferon-beta for the treatment of metastatic breast cancer
L. Repetto, P. Giannessi, E. Campora, P. Pronzato +5 more
2005Breast Cancer Research and Treatment20 citations Open access
Semantic Scholar
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer
G. Gardin, A. Alama, R. Rosso, E. Campora +10 more
2004Breast Cancer Research and Treatment15 citations
Semantic Scholar
A Randomized Trial of Chemotherapy with or without Estrogenic Recruitment in Locally Advanced Breast Cancer
E. Baldini, G. Gardin, P. Giannessi, F. Brema +9 more
1997Tumori10 citations Open access
Semantic Scholar
Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
A. Michelotti, A. Gennari, B. Salvadori, P. Giannessi +4 more
1996Seminars in Oncology10 citations
Semantic Scholar
In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinoma.
E. Baldini, P. Giannessi, G. Gardin, A. Alama +3 more
1994Journal of Biological Regulators and Homeostatic Agents10 citations
Semantic Scholar
Activity and safety of epirubicin plus paclitaxel in advanced breast cancer.
P. Conte, A. Michelotti, E. Baldini, C. Tibaldi +6 more
1996Seminars in Oncology9 citations
Semantic Scholar
Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study.
L. Del Mastro, M. Venturini, P. Giannessi, A. Vigani +6 more
1995Anticancer Research9 citations
Semantic Scholar
Effects of Primary Chemotherapy on Biological Parameters of Locally Advanced Breast Cancer a
Paola Collecchi, P. Giannessi, E. Baldini, A. Naccarato +3 more
1996Annals of the New York Academy of Sciences5 citations Open access
Semantic Scholar
Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas.
A. Michelotti, Antonella Romanini, P. Giannessi, Carmelo Bengala +1 more
1996American Journal of Clinical Oncology5 citations
Semantic Scholar
Evaluation of Taxol Cardiotoxicity in Metastatic Breast Cancer
O. Biadi, G. Mengozzi, G. Gherarducci, G. Strata +5 more
1993Annals of the New York Academy of Sciences5 citations Open access
Semantic Scholar
Gemcitabine in combination with capecitabine in metastatic breast carcinoma: A phase I-II study
P. Giannessi, F. Martella, R. Di Marsico, L. Coltelli +3 more
20054 citations
Semantic Scholar
Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients.
E. Baldini, C. Tibaldi, M. Lencioni, P. Giannessi +6 more
1997American Journal of Clinical Oncology4 citations
Semantic Scholar
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
P. Conte, E. Baldini, A. Michelotti, B. Salvadori +5 more
1996Seminars in Oncology4 citations
Semantic Scholar
Stimulation of Human Breast Cancer in Vivo
E. Baldini, G. Gardin, C. Naso, P. Pronzato +13 more
1993Annals of the New York Academy of Sciences3 citations
Semantic Scholar
The Role of Lonidamine in the Treatment of Breast Cancer Patients
R. Rosso, G. Gardin, P. Pronzato, A. Camoriano +11 more
1993Annals of the New York Academy of Sciences3 citations
Semantic Scholar
Combination of trastuzumab, oxaliplatin, and docetaxel as first-line treatment in HER2-positive metastatic breast cancer patients: First-step results of a phase II trial (HOT trial).
D. Amoroso, S. Donati, C. Valsuani, Cheti Puccetti +6 more
2016Journal of Clinical Oncology2 citations
Semantic Scholar
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial.
L. Livraghi, F. Martella, M. Ghilli, Catia Angiolini +18 more
2024European Journal of Cancer1 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy in cervical cancer patients: a single institution experience.
Matilde Destefanis, M. Filippeschi, G. Zipoli, P. Dentico +7 more
20161 citations
Semantic Scholar
Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
G. Fiorentini, M. Filippeschi, G. Turrisi, A. Mambrini +7 more
2009In Vivo1 citations
Semantic Scholar
Vemurafenib and aPTT prolonging: A case report.
S. Rossi, Buggiani Antonio, P. Dentico, Paolo Bernardeschi +7 more
20140 citations
Semantic Scholar
Combination of trastuzumab, oxaliplatin and docetaxel as first line treatment in HER2-positive advanced breast cancer patients: preliminary results of a phase II trial (HOT Trial)
D. Amoroso, S. Donati, M. Rondini, C. Valsuani +7 more
20090 citations
Semantic Scholar
Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records
P. Bernardeschi, G. Fiorentini, P. Dentico, S. Rossi +5 more
2008Leukemia0 citations Open access
Semantic Scholar
Phase II trial nof non-pegylated liposomal doxorubicin (MYOCET ® ) associated with weekly docetaxel in metastatic breast cancer
V. Safina, N. Giuntini, L. Coltelli, F. Martella +4 more
20070 citations
Semantic Scholar
A Pilot Study of a Day One and Eight Every Three Weeks Administration of Docetaxel in Metastatic Cancer Patients
F. Martella, P. Giannessi, R. Di Marsico, L. Coltelli +3 more
2007Tumori0 citations
Semantic Scholar
The role of transvaginal ultrasound in early diagnosis of tamoxifen-related endometrial cancer: An Italian experience
F. Martella, P. Giannessi, L. Coltelli, N. Giuntini +2 more
20070 citations
Semantic Scholar
[The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: the example of clinical studies].
P. Giannessi
2004I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]0 citations
Semantic Scholar
582 A phase I study of day 1 and 8 every three weeks docetaxel infusion
P. Giannessi, R. Di Marsico, F. Martella, C. Galli +4 more
20030 citations
Semantic Scholar
POSTER: TOPICS Breast Cancer Lung Cancer, Head and Neck Cancer Gastro Intestinal Malignancies Genito-Urinary Tract Cancer Hemolinphoproliferative Melanoma and Sarcoma Supportive Care and Quality of Life Miscellanea
Pasquini, S. Bartolirn, Passoni, P. Piscopo +3 more
19960 citations
Semantic Scholar
122 O - A phase I trial of epirubicin (E) and paclitaxel (P) in patients with metastatic breast cancer (MBC)
R. Salyadori, A. Mlchelotti, E. Baldini, A. Gennari +5 more
19960 citations
Semantic Scholar
512 Taxol (tax) and escalating doses of ifosfamide (IFO) in advanced breast and ovarian cancer patients (PTS)
A. Romanini, P. Giannessi, M. Conti, M. Da Prato +4 more
19950 citations
Semantic Scholar
934 Paclitaxel (P) and epirubicin (E) in advanced breast (ABC) and ovarian cancer (AOC): A phase I study
P. Conte, A. Michelotti, A. Romanini, E. Baldini +9 more
19950 citations
Semantic Scholar
High risk breast cancer patients: An intensive adjuvant regimen administered with or without G-CSF
E. Batdini, M. Lencioni, C. Tibatdi, P. Giannessi +1 more
19940 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Baldini×15
Invite
E. Baldini — researcher profile on SciRah
P. Conte×11
Invite
P. Conte — researcher profile on SciRah
G. Gardin×7
Invite
G. Gardin — researcher profile on SciRah
A. Falcone×7
Invite
A. Falcone — researcher profile on SciRah

×6

Invite

B. Salvadori — researcher profile on SciRah

Invite

P. Conte — researcher profile on SciRah

Invite

C. Tibaldi — researcher profile on SciRah

Invite

F. Martella — researcher profile on SciRah

Invite

R. Rosso — researcher profile on SciRah

A. Michelotti×5

Invite

A. Michelotti — researcher profile on SciRah

Invite

F. Carnino — researcher profile on SciRah

Invite

R. Rosso — researcher profile on SciRah